Clinical Trials

Colorectal Neoplasms

NCT03869892 2025-12-22

SOLSTICE

856 enrolled

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT04835142 2025-12-05

Comparison of A140 and Erbitux Combined With mfolfox6 to Evaluate Efficacy and Safety of First-line Treatment for Ras Wild-type mCRC

688 enrolled

Colorectal Neoplasms

NCT04008030 2025-10-03

CheckMate 8HW

839 enrolled 22 charts 1 FDA

Colorectal Neoplasms

NCT05064059 2025-09-17

MK-4280A-007

441 enrolled 24 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

NCT06614192 2025-08-26

A Study Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer

Phase 3 Recruiting

460 enrolled

Phase 3 Not yet recruiting

Colorectal Neoplasms

NCT07134205 2025-08-21

The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal Cancer

252 enrolled

Colorectal Neoplasms

NCT04607421 2025-08-14

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

831 enrolled 2 FDA

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms

NCT05328908 2025-08-13

RELATIVITY-123

Phase 3 Terminated

770 enrolled

Phase 3 Not yet recruiting

Spinocerebellar Degenerations, Colorectal Neoplasms

NCT07025239 2025-06-17

QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer

430 enrolled

Colorectal Neoplasms

NCT04322539 2025-04-04

FRESCO-2

691 enrolled 26 charts 1 FDA

Colonic Neoplasms, Colorectal Neoplasms

NCT04793958 2025-02-11

KRYSTAL-10

461 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT03511963 2024-12-31

A Clinical Study to Compare the Efficacy, Safety and Immunogenicity of HLX04 and Bevacizumab Combined XELOX or mFOLFOX6 in the First-line Treatment of mCRC

677 enrolled

Colorectal Neoplasms

NCT04456699 2024-10-29

LYNK-003

335 enrolled 19 charts

Colorectal Neoplasms

NCT02563002 2024-10-03

KEYNOTE-177

307 enrolled 16 charts 2 FDA

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

NCT04737187 2024-09-24

SUNLIGHT

492 enrolled 22 charts 1 FDA

Colorectal Neoplasms

NCT01607957 2024-09-19

RECOURSE

800 enrolled 12 charts

Colorectal Neoplasms

NCT05223673 2024-08-20

COLSTAR

Phase 3 Terminated

7 enrolled 12 charts

Neoplasm Metastasis, Colorectal Neoplasms

NCT03306394 2024-07-25

PRECONNECT

907 enrolled

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT03659448 2024-04-24

Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer

Phase 3 Recruiting

300 enrolled

Neoplasms, Colorectal Neoplasms

NCT02928224 2023-12-21

BEACON CRC

702 enrolled 82 charts 2 FDA

Colorectal Neoplasms

NCT02753127 2023-11-15

CanStem303C

1,253 enrolled 18 charts